Connected Health Conference: All in One Day Countdown Has Begun

A familiar story unfolds every day around the world: a patient learns that he or she has a cancer diagnosis. In past years, this situation usually meant entering into a standardized treatment program with painful side effects that may or may not work.

But instead of going through disruptive chemotherapy that can kill healthy cells along with cancerous cells, what would happen if these patients were able to be treated as individuals based on their specific genome sequencing, and a precision treatment plan could be tailored specifically for their disease? And what if it could happen within 24 hours?

That’s the vision that Intel laid out last year when it announced the All in One Day initiative. The end goal is to empower researchers and doctors to help patients receive a diagnosis based on their genome and potentially arm clinicians with the data needed for a targeted treatment plan. By 2020, we envision this happening in 24 hours -- All in One Day. The focus is to help cancer centers worldwide—and eventually centers for other diseases—securely share their private clinical and research data with one another to generate larger datasets to benefit research and inform the specific treatment of their individual patients.

At the upcoming Connected Health Conference, I invite you to attend an important panel discussion in the main Potomac Ballroom at 9:55 a.m. on Monday, Dec. 12, that will explore the road to All in One Day. Achieving this vision in just three more years will require new capabilities, and speed, in personal health and genomic data storage, transfer and analysis as well as interoperability. Further, precision medicine will demand new regulatory approaches for review and approval of genomic sequencing technologies and other software and devices needed to advance knowledge of disease factors that demonstrate variability among individuals. Using The Precision Medicine Initiative as context, panelists representing perspectives from policy, clinical care, patient advocacy and technology will discuss the barriers to achieving the vision for All in One Day precision medicine.

I look forward to seeing you at the Connected Health Conference and hearing your thoughts on how healthcare technology can lead the way toward achieving a personalized approach to patient care.